Conversion and resection rates in borderline resectable and locally advanced pancreatic cancer following neoadjuvant therapy: a retrospective multicenter cohort study.

Front Oncol · 2026 · PMC13229634 · PMID 42245695

Europe PMC DOI

hedged sentences

0.1200

closest p · 2.4× alpha

0.1200

boldest claim

The sentences

a notable trendp=0.12not close (p > 0.1)

18%; Fisher’s exact p=0.03) and a notable trend toward improved progression-free survival (PFS; 14.2 vs. 6.1 months; HR 0.52; p=0.12 ( Table 4 )).

also in 2,380 other papers

did not reach statistical significanceno p-value reported

Elevated pre-treatment CA19–9 levels were associated with a trend towards worse OS (HR 1.8, 95% CI 0.9–3.6), but this association did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.